|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01858 CHUNLI MEDICAL
Nominal 
17.650 +0.440 (+2.557%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (1,900) | 511,714 | 41,008 | 164,786 |
| Net Cash from / (used in) Investing Activities | -- | 55,836 | (81,556) | (762,612) | (190,347) |
| Net Cash from / (used in) Financing Activities | -- | (183,139) | (121,334) | (59,036) | 1,073,663 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (129,203) | 308,824 | (780,640) | 1,048,102 |
| Cash & Cash Equivalents at beginning of period | -- | 1,266,013 | 957,194 | 1,736,494 | 690,116 |
| Effect of Foreign Exchange Rate Changes | -- | 2,208 | (4) | 1,340 | (1,724) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,139,018 | 1,266,013 | 957,194 | 1,736,494 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 114,469 |
| %Change | 44.850% |
| EPS / (LPS) | RMB 0.300 |
| NBV Per Share (¥) | RMB 7.608 |